MRI has upper hand on CT for ovarian cancer detection
May 13, 2022 -- MRI has advantages over CT when it comes to detecting and characterizing ovarian masses, but more data is needed, according to a presentation on 11 May at the International Society for Magnetic Resonance in Medicine meeting. Read More
Diffusion-weighted MRI models can classify breast lesions
May 13, 2022 -- Diffusion-weighted MR imaging models can differentiate between malignant and benign breast lesions, according to research presented on 11 May at the International Society for Magnetic Resonance in Medicine meeting. Read More
Video from ISMRM 2022: Why Nandita deSouza loves the congress
May 10, 2022 -- LONDON - Radiologist and cancer imaging expert Prof. Nandita deSouza, PhD, has attended nearly every annual meeting of the International Society for Magnetic Resonance in Medicine (ISMRM) since 1991. In this interview, she explains why she returns year after year. Read More
Diffusion-weighted MRI shows promise in breast imaging
May 10, 2022 -- Diffusion-weighted imaging (DWI) derived from MRI can help reduce unnecessary biopsies in breast cancer screening, according to presentations given on 9 May at the annual meeting of the International Society for Magnetic Resonance in Medicine. Read More
Video from ISMRM 2022: Katja Pinker-Domenig on breast MRI
May 9, 2022 -- LONDON - How do they use breast MRI at the world-famous Memorial Sloan Kettering Cancer Center in New York? What impact has the pandemic had on screening for breast cancer? Leading researcher Dr. Katja Pinker-Domenig, PhD, provides some answers in a video interview. Read More
Momentum gathers for DBT plus synthesized mammography
April 27, 2022 -- German authors have found digital breast tomosynthesis (DBT) combined with synthesized mammography can detect more invasive breast cancers than digital mammography alone. They published the results of a study of nearly 100,000 women in Lancet Oncology. Read More
Will new growth stem from the 1B euro Affidea deal?
April 26, 2022 -- The acquisition of imaging operator Affidea by Belgian investment firm Groupe Bruxelles Lambert reveals much about the future shape of radiology and the major market trends, but can the growth continue and where are the key opportunities? Industry analyst Steve Holloway has the answers. Read More
Copenhagen study confirms AI's value in breast screening
April 25, 2022 -- Danish investigators have shown an artificial intelligence (AI) algorithm detected and categorized normal, moderate-risk, and suspicious mammograms while also performing consistently across breast densities. The technology can improve screening outcomes, they say. Read More
Attention turns to radiation safety in breast screening
April 21, 2022 -- Radiation protection is vital in breast screening exams with x-ray technology, particularly given the increasing use of more complicated and potentially more radiation-intensive procedures such as tomosynthesis and contrast mammography. That's the view of a leading European expert on breast imaging. Read More
GBL to acquire European imaging operator Affidea for 1B euros
April 19, 2022 -- Belgian investment firm Groupe Bruxelles Lambert (GBL) announced on 19 April that it is making its first sizable investment in healthcare by acquiring imaging operator Affidea for approximately 1 billion euros. Read More